Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 78Terminated 19Unknown 16Withdrawn 7Active not recruiting 6Recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Myeloid 2Lymphoid 2Classical hematology 2Plasma cell 1Other hematologic neoplasm 1Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 16Myelodysplastic Syndromes 12Multiple Myeloma 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Hematologic Neoplasms 6Neuroblastoma 5Hodgkin Disease 5Retinoblastoma 4Lymphoma, Non-Hodgkin 4Graft vs Host Disease 4Anemia, Refractory, with Excess of Blasts 4Myeloproliferative Disorders 3Leukemia, Myelomonocytic, Chronic 3Recurrence 2Primary Myelofibrosis 2Myelodysplastic-Myeloproliferative Diseases 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Biphenotypic, Acute 2Leukemia, B-Cell 2Leukemia 2Ganglioneuroblastoma 2Anemia, Aplastic 2beta-Thalassemia 1Venentoclax 1Thrombocythemia, Essential 1Sarcoma, Ewing 1Rhabdomyosarcoma 1

Interventions

Cyclophosphamide 28fludarabine 19Rituximab 17obinutuzumab 12venetoclax 10Lenalidomide 9Bendamustine Hydrochloride 9Prednisone 7zanubrutinib 6Doxorubicin 6Blood Specimen Collection 6pembrolizumab 5ibrutinib 5fludarabine phosphate 5Biopsy 5glofitamab 4Vincristine 4Trimethoprim, Sulfamethoxazole Drug Combination 4Exercise 4loncastuximab tesirine 3gamma-Globulins 3axicabtagene ciloleucel 3acalabrutinib 3Temozolomide 3Surveys and Questionnaires 3Palliative Care 3Mycophenolic Acid 3Methotrexate 3Mesna 3Magnetic Resonance Spectroscopy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Lymphoma × Melphalan × Clear all
NCT05589896 2026-02-24

A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies

Ossium Health, Inc.

Phase 1/2 Recruiting
12 enrolled
Classical hematologyDermatologicLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Hematologic Diseases, Hodgkin Disease, Leukemia, Lymphoma, Leukemia, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Cutaneous, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03016806 2025-10-10

Umbilical Cord Blood Transplantation From Unrelated Donors

University of Rochester

Recruiting
30 enrolled
Classical hematologyLymphoidMyeloidPlasma cell

Anemia, Aplastic, Immunologic Deficiency Syndromes, Lymphoma, Metabolic Diseases, Multiple Myeloma, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡